The Russell 3000 index’s underlying components experienced an influx of options trading on Wednesday, with three companies standing out for particularly high volume. Rapid7 Inc (Symbol: RPD) took the lead, with a trading volume of 6,367 contracts, representing approximately 636,700 underlying shares. This amount constitutes an impressive 72.8% of RPD’s average daily trading volume over the past month, which rested at 875,030 shares. Notably, the $60 strike call option expiring May 17, 2024, stole the show, with 2,633 contracts trading so far on Wednesday, symbolizing approximately 263,300 underlying shares of RPD.
Following closely, Emergent BioSolutions Inc (Symbol: EBS) witnessed options trading volume of 8,531 contracts, representing roughly 853,100 underlying shares or about 65.6% of EBS’s average daily trading volume over the last month, which amounted to 1.3 million shares.
The $5 strike call option expiring March 15, 2024, also made waves, with 2,809 contracts trading on Wednesday, equating to roughly 280,900 underlying shares of EBS. Below is a chart of EBS’s trailing twelve month trading history, with the $5 strike highlighted in orange:
Lastly, Medical Properties Trust Inc (Symbol: MPW) also had a notable day, seeing options trading volume of 122,139 contracts. This represented approximately 12.2 million underlying shares or some 64.6% of MPW’s average daily trading volume over the last month, which stood at 18.9 million shares. Of particular interest was the $3 strike put option expiring February 23, 2024, as it saw 19,863 contracts trading on Wednesday, signifying roughly 2.0 million underlying shares of MPW. Below is a chart showing MPW’s trailing twelve month trading history, with the $3 strike highlighted in orange:
For more specific information on the various expiration dates available for RPD options, EBS options, or MPW options, interested parties can visit StockOptionsChannel.com.
Additional Resources:
Dive into Cheap Midcap Stocks
Explore SBOW market cap history
Stay informed with the NTSP Options Chain
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
